Inventor
BOGDAN ANDREW
US20 patents
⚠️ This page may combine multiple inventors who share the name “BOGDAN ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE SARL
6 patentsUS10118916B2Nov 6, 2018
Modulators of cystic fibrosis transmembrane conductance regulator protein
ABBVIE SARL30 citations93
US10138227B2Nov 27, 2018
Heteroaryl substituted pyridines and methods of use
ABBVIE SARL31 citations92
US9981910B2May 29, 2018
Substituted pyrrolidines and methods of use
ABBVIE SARL31 citations92
US10399940B2Sep 3, 2019
Substituted pyrrolidines and methods of use
ABBVIE SARL4 citations71
US10604515B2Mar 31, 2020
Heteroaryl substituted pyridines and methods of use
ABBVIE SARL1 citations61
US10428017B2Oct 1, 2019
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE SARL1 citations61
ABBVIE INC
6 patentsUS8980879B2Mar 17, 2015
Bromodomain inhibitors
ABBVIE INC11 citations83
US10085985B2Oct 2, 2018
Bromodomain inhibitors
ABBVIE INC2 citations73
US9969693B2May 15, 2018
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
ABBVIE INC3 citations72
US9452986B2Sep 27, 2016
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
ABBVIE INC5 citations72
US10035800B2Jul 31, 2018
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
ABBVIE INC3 citations70
US9428514B2Aug 30, 2016
Bromodomain inhibitors
ABBVIE INC1 citations52
ABBVIE OVERSEAS SARL
5 patentsUS10988454B2Apr 27, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL1 citations70
US10981890B2Apr 20, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations59
US10844041B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10844042B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10829473B2Nov 10, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49